US Stock MarketDetailed Quotes

PYXS Pyxis Oncology

Watchlist
  • 3.360
  • -0.070-2.04%
Close Aug 16 16:00 ET
  • 3.360
  • 0.0000.00%
Post 20:01 ET
198.05MMarket Cap-2645P/E (TTM)

Pyxis Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
16.15M
0
0
0
0
0
0
0
0
Operating revenue
--0
--16.15M
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
0
475K
0
0
Gross profit
0
15.67M
0
0
Operating expense
10.55%20.03M
1.54%21.28M
-33.43%82.2M
-53.21%17.77M
-10.70%25.35M
-29.56%18.12M
-33.24%20.95M
77.12%123.48M
131.18%37.97M
144.32%28.39M
Selling and administrative expenses
-9.67%6.08M
-8.90%8.25M
-12.70%32.61M
-24.13%6.16M
13.98%10.67M
-21.34%6.73M
-20.01%9.05M
100.14%37.35M
-11.75%8.12M
148.12%9.36M
-General and administrative expense
-9.67%6.08M
-8.90%8.25M
-12.70%32.61M
-24.13%6.16M
13.98%10.67M
-21.34%6.73M
-20.01%9.05M
100.14%37.35M
-11.75%8.12M
148.12%9.36M
Research and development costs
22.49%13.95M
9.48%13.03M
-42.43%49.59M
-61.12%11.61M
-22.84%14.69M
-33.66%11.39M
-40.71%11.9M
68.70%86.13M
313.15%29.85M
142.50%19.03M
Operating profit
-10.55%-20.03M
73.25%-5.61M
33.43%-82.2M
53.21%-17.77M
10.70%-25.35M
29.56%-18.12M
33.24%-20.95M
-77.12%-123.48M
-131.18%-37.97M
-144.32%-28.39M
Net non-operating interest income expense
22.16%2.02M
-7.35%1.55M
139.87%6.63M
-14.85%1.59M
137.41%1.71M
909.76%1.66M
18,488.89%1.67M
11,917.39%2.76M
26,642.86%1.87M
11,883.33%719K
Non-operating interest income
22.16%2.02M
-7.35%1.55M
139.87%6.63M
-14.85%1.59M
137.41%1.71M
909.76%1.66M
18,488.89%1.67M
11,917.39%2.76M
26,642.86%1.87M
11,883.33%719K
Other net income (expense)
25.53%708K
2,002.63%799K
1.78M
576K
598K
564K
38K
Other non- operating income (expenses)
25.53%708K
2,002.63%799K
--1.78M
--576K
--598K
--564K
--38K
----
----
----
Income before tax
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
Income tax
Net income
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
Net income continuous Operations
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
Minority interest income
Net income attributable to the parent company
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.80%-17.3M
83.08%-3.26M
38.87%-73.79M
56.80%-15.6M
16.71%-23.05M
37.79%-15.9M
38.68%-19.24M
-58.89%-120.72M
-114.52%-36.1M
-95.23%-27.67M
Basic earnings per share
29.27%-0.29
88.89%-0.06
49.32%-1.85
68.27%-0.33
34.12%-0.56
48.10%-0.41
44.33%-0.54
59.22%-3.65
-99.13%-1.04
-90.29%-0.85
Diluted earnings per share
29.27%-0.29
88.89%-0.06
49.32%-1.85
68.27%-0.33
34.12%-0.56
48.10%-0.41
44.33%-0.54
59.22%-3.65
-99.13%-1.04
-90.29%-0.85
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 016.15M00000000
Operating revenue --0--16.15M--0--0--0--0--0--0--0--0
Cost of revenue 0475K00
Gross profit 015.67M00
Operating expense 10.55%20.03M1.54%21.28M-33.43%82.2M-53.21%17.77M-10.70%25.35M-29.56%18.12M-33.24%20.95M77.12%123.48M131.18%37.97M144.32%28.39M
Selling and administrative expenses -9.67%6.08M-8.90%8.25M-12.70%32.61M-24.13%6.16M13.98%10.67M-21.34%6.73M-20.01%9.05M100.14%37.35M-11.75%8.12M148.12%9.36M
-General and administrative expense -9.67%6.08M-8.90%8.25M-12.70%32.61M-24.13%6.16M13.98%10.67M-21.34%6.73M-20.01%9.05M100.14%37.35M-11.75%8.12M148.12%9.36M
Research and development costs 22.49%13.95M9.48%13.03M-42.43%49.59M-61.12%11.61M-22.84%14.69M-33.66%11.39M-40.71%11.9M68.70%86.13M313.15%29.85M142.50%19.03M
Operating profit -10.55%-20.03M73.25%-5.61M33.43%-82.2M53.21%-17.77M10.70%-25.35M29.56%-18.12M33.24%-20.95M-77.12%-123.48M-131.18%-37.97M-144.32%-28.39M
Net non-operating interest income expense 22.16%2.02M-7.35%1.55M139.87%6.63M-14.85%1.59M137.41%1.71M909.76%1.66M18,488.89%1.67M11,917.39%2.76M26,642.86%1.87M11,883.33%719K
Non-operating interest income 22.16%2.02M-7.35%1.55M139.87%6.63M-14.85%1.59M137.41%1.71M909.76%1.66M18,488.89%1.67M11,917.39%2.76M26,642.86%1.87M11,883.33%719K
Other net income (expense) 25.53%708K2,002.63%799K1.78M576K598K564K38K
Other non- operating income (expenses) 25.53%708K2,002.63%799K--1.78M--576K--598K--564K--38K------------
Income before tax -8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M
Income tax
Net income -8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M
Net income continuous Operations -8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M
Minority interest income
Net income attributable to the parent company -8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.80%-17.3M83.08%-3.26M38.87%-73.79M56.80%-15.6M16.71%-23.05M37.79%-15.9M38.68%-19.24M-58.89%-120.72M-114.52%-36.1M-95.23%-27.67M
Basic earnings per share 29.27%-0.2988.89%-0.0649.32%-1.8568.27%-0.3334.12%-0.5648.10%-0.4144.33%-0.5459.22%-3.65-99.13%-1.04-90.29%-0.85
Diluted earnings per share 29.27%-0.2988.89%-0.0649.32%-1.8568.27%-0.3334.12%-0.5648.10%-0.4144.33%-0.5459.22%-3.65-99.13%-1.04-90.29%-0.85
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg